Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Odonate Therapeutics, LLC (ODT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10yOdonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.

Sector: Healthcare
Industry: Pharmaceuticals

CEO: Kevin C. Tang
http://www.odonate.com
Price: $28.04 Metrics
OS: 14.2 M
Market cap: $397 M
Net cash: $198 M $13.98 per share
EV: $199 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues27.92.60.0
            Revenue growth964.1%  
Cost of goods sold32.73.10.2
Gross profit-4.8-0.5-0.2
            Gross margin-17.4%-17.7% 
Selling, general and administrative  0.0
General and administrative4.80.50.0
EBIT-37.6-3.5-0.2
            EBIT margin-134.7%-135.3% 
Pre-tax income-32.7-3.10.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-32.7-3.10.0
            Net margin-117.4%-117.7% 
 
Diluted EPS($2.31)($0.54) 
Shares outstanding (diluted)14.25.8 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy